Medical diagnostics is undergoing a rapid transformation, and United Imaging is at the forefront of this change. Through a combination of advanced technology, artificial intelligence and thoughtful ...

This new wearable system uses advanced specialty lighting and appropriate optical filters to provide the required lighting to perform fluorescent-guided removal of malignant brain tumors, such as ...

"The recognition of Breakthrough Device Designation for the eShunt System in pediatric aged patients demonstrates the profound need for treatment innovation in this patient population and reinforces ...

“Nalu Medical has made tremendous strides commercially and clinically in the past two years. Novo’s investment in Nalu reflects that progress and the confidence they share in the strong commercial ...

Positive guidance for the Boston Scientific FARAPULSE™ Pulsed Field Ablation System marks expansion of minimally invasive treatment options for growing number of atrial fibrillation patients in the UK ...

Jill realized that there was an opportunity to create an entirely new way to treat OAB and focus on the patient experience – ensuring that the treatment was not only effective but also eliminated the ...

The FDA approved this treatment under a compassionate. Precisio announced a first-in-man dosing of its staph lysin called ClyO (LYSG101) to a patient with a prosthetic joint infection that had not ...

PolarSeal®, the flexible medical device partner, today announces the appointment of Chris Locke as Chief Technology Officer (CTO) – a key strategic move that reinforces its commitment to enabling ...

MitraClip G5 offers physicians easy handling, precise positioning and intuitive deployment that enhances both control and efficiency. Interventional cardiologist Dr. Augusto Villa performed the ...

The MR-139 3001 Phase 3 trial consisted of a randomized, placebo-controlled, double-masked prospective study, with a total of 477 patients who were randomized to receive either MR-139 or placebo, self ...

Findings from the first prospective validation trial for biomarker presented at ASTRO 2025 Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, announced that new data from the ...

This agreement includes the first 400 cm, 0.018" peripheral guidewire available in the U.S, expanding the Medtronic portfolio for transradial access for the treatment of peripheral arterial disease ...